BioTherapeutics | 1800 Kraft Dr., Suite 200, Blacksburg, VA, 24060

BioTherapeutics CEO Named 2017 Innovator of the Year by Roanoke-Blacksburg Technology Council

BioTherapeutics CEO Named 2017 Innovator of the Year by Roanoke-Blacksburg Technology Council

BLACKSBURG, VA. April 24, 2017 —The Roanoke-Blacksburg Technology Council (RBTC) recognized a talented group of companies and individuals at its annual TechNite awards banquet, which was held at the Hotel Roanoke & Conference Center on April 21, 2017. TechNite is an annual celebration of the Roanoke - Blacksburg region’s technology community.

Nominations were accepted for five awards: STEM-H Educator, Entrepreneur, Innovator, Regional Leadership, and Rising Star.

“The Innovator Award recognizes an individual, a group of individuals, company, or other organization that sets the standard for thought leadership and innovation in their respective field,” says RBTC President Robert McAden. “By definition, they are doing something new or different, and they are doing it well. Their innovation represents a significant technological breakthrough.”

President and CEO of BioTherapeutics, Inc. (BTI), Josep Bassaganya-Riera, was selected as the winner of the 2017 RBTC’s Innovator of the Year award. He is a serial entrepreneur who founded three local biotech companies in the Virginia Tech Corporate Research Center, and leads the Nutritional Immunology and Molecular Medicine Laboratory at the Biocomplexity Institute of Virginia Tech. He has a demonstrated track record of successfully leveraging advanced informatics and computational modeling to accelerate the development of innovative technologies into marketable nutritionals and therapeutics for inflammatory bowel disease.

“It is a distinct honor and a privilege to accept the 2017 Innovation Award from the RBTC,” says Bassaganya-Riera. “Transformative innovation is only possible with the unwavering resolve, hard work, loyalty and dedication of a fantastic group of individuals. I am proud that our team shares a vision for the future of precision medicine and health.”

Bassaganya-Riera discusses his innovative vision for precision medicine during Virginia Tech’s most recent TEDx event. In his discussion, he explains how modeling and simulation of immunological systems helps capture human variation and diversity and offers clinicians and patients a more rapid pipeline between clinical trials and personalized, individual treatments for human diseases.

Immediately impacting the Roanoke/Blacksburg Region is the national launch of Bassaganya-Riera’s Pervida® brand of nutritional products. Available in limited quantities this May, the naturally flavored, zero-calorie Pervida® Immune is crisp and refreshing, and benefits from the scientifically proven, patented ingredient punicic acid (PUA).

PUA is a rare fatty acid found naturally in pomegranate seed oil (PSO) that supports gut health, and boosts immunity. The cold-press method Pervida® Immune employs for extracting PSO from seeds produces no heat, thereby ensuring the highest quality of PSO. Over 500 pounds of fresh pomegranates are required to produce just over one pound of PUA-rich PSO, and currently there are no beverages on the market that feature PSO, not even pomegranate juice.

“In line with our innovative vision,” continues Bassaganya-Riera, “we are very excited about launching the first Pervida® brand health water, a category innovator in the beverage industry. The launch of Pervida® Immune is the culmination of a decade of research leading to the development of a new class of products for personalized nutrition and health promotion.”

About Pervida® – From Nature’s Innovations

“Pervida® is a Catalan word meaning “for life.” Pervida® encompasses a series of health-and-wellness food and beverage products launching Spring 2017 that address unmet consumer needs for living healthier, longer, better and more productive lives. The Pervida® brand is the vision of entrepreneur Dr. Josep Bassaganya-Riera. Pervida® will deliver innovative heath products containing naturally occurring active ingredients with scientifically proven health benefits.

Related Press Releases:

TEDx: https://biotherapeuticsinc.com/index.php/news/detail/tedx-virginia-tech-accelerated-path-to-cures

Pervida®: http://pervida.net/pervida-launches-with-flagship-product-pervida-immune

BT-11: https://biotherapeuticsinc.com/index.php/news/detail/bt-11-oral-therapeutic-for-inflammatory-bowel-disease

Precision Medicine: https://biotherapeuticsinc.com/index.php/news/detail/precision-medicine-and-health-at-biotherapeutics

Back to top